when it's okay to combine renin-angiotensin system blockers...ACEIs, ARBs, or aliskiren (Tekturna, etc)

See the FDA's April 2012 safety notice concerning the use of Aliskiren (Tekturna) with ACEIs or ARBs

You'll hear debate about when it's okay to combine renin-angiotensin system blockers...ACEIs, ARBs, or aliskiren (Tekturna, etc).

Some experts hoped that combining these would improve outcomes.

But there's growing evidence that these combos usually DON'T provide any additional benefit...and are sometimes harmful.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote